These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle.
    Author: Wiser A, Gilbert A, Nahum R, Orvieto R, Haas J, Hourvitz A, Weissman A, Younes G, Dirnfeld M, Hershko A, Shulman A, Tsafrir A, Holzer H, Shalom-Paz E, Tulandi T.
    Journal: Reprod Biomed Online; 2013 May; 26(5):449-53. PubMed ID: 23518030.
    Abstract:
    Ectopic pregnancy is a known risk for patients treated with IVF. The objective of this study was to evaluate the effect of methotrexate (MTX) and laparoscopic salpingectomy as treatments of ectopic pregnancy on ovarian response during IVF cycles. Data of all women treated for ectopic pregnancy as a result of IVF treatment were evaluated; the study included women who had an unruptured ectopic pregnancy after IVF treatment that was treated with either MTX or laparoscopic salpingectomy and underwent a subsequent IVF cycle. The main outcome measures were baseline serum FSH concentrations and ovarian response in the subsequent IVF cycle after treatment of ectopic pregnancy. Of a total of 58 patients, 36 were previously treated with MTX and 22 others by salpingectomy. No significant differences were observed between the MTX and the salpingectomy groups in the parameters of ovarian response in the subsequent IVF cycle.
    [Abstract] [Full Text] [Related] [New Search]